no evidence of disease activity as a predictive measure of long-term disability in rrms
Published 3 years ago • 154 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
4:03
the predictive value of neda-3 for long-term disability in ms
-
5:12
no evidence of disease activity (neda): the goal of multiple sclerosis (ms) treatment
-
3:13
snfl as a predictor of 10-year gray matter atrophy and clinical disability in ms
-
4:46
early predictors of long-term disability in pediatric ms
-
4:27
low serum contactin-1 predicts disability progression in ms
-
2:27
no evidence of disease activity with ocrelizumab for multiple sclerosis
-
1:34
the impact of social networks on physical impairment in ms
-
2:13
disparate disability accumulation in multiple sclerosis
-
5:51
relapse in multiple sclerosis: a hallmark of disease
-
0:59
multiple sclerosis and the devil's trick 😈. don't fall for it!
-
2:30
four-year efficacy and safety of evobrutinib for relapsing ms
-
2:22
long-term safety and efficacy of tolebrutinib for relapsing multiple sclerosis
-
2:26
ensemble learning methods predict disease course in ms
-
4:47
can i qualify for long-term disability insurance benefits as a result of insomnia / sleep disorders?
-
2:28
assessing novel biomarkers: retinal layer atrophy in pms vs. rrms
-
7:20
cognitive dysfunction and disorders in long term disability claims
-
5:02
assessing outcomes in ms relapse: using arms and edss
-
7:23
parting advice on treating multiple sclerosis relapse
-
4:53
what to do before you stop working and apply for long-term disability benefits due to a stroke